trending Market Intelligence /marketintelligence/en/news-insights/trending/9H0C_OVTBOJIRKxu72LCdw2 content esgSubNav
In This List

Organovo expands board with addition of new director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Organovo expands board with addition of new director

Organovo Holdings Inc. appointed David Shapiro as a director, increasing the size of its board to eight members.

Shapiro has served as the chief medical officer of Intercept Pharmaceuticals Inc. since November 2017.

Organovo is a biotech platform company providing 3D bioprint tissues with human functionality.